Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics
     
Yazarlar (6)
Mudassir Hassan Government College University Faisalabad, Pakistan
Dr. Öğr. Üyesi Lütfi TUTAR Kırşehir Ahi Evran Üniversitesi, Türkiye
Duygu Sarı Ak University Of Health Sciences, Türkiye
Azhar Rasul Government College University Faisalabad, Pakistan
Ejaz Basheer Government College University Faisalabad, Pakistan
Yusuf Tutar Recep Tayyip Erdoğan Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Translational Oncology (Q2)
Dergi ISSN 1936-5233 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 09-2024
Cilt / Sayı / Sayfa 47 / 1 / 102055–102055 DOI 10.1016/j.tranon.2024.102055
Makale Linki https://doi.org/10.1016/j.tranon.2024.102055
Özet
Breast cancer (BC) is a complex and multifactorial disease, driven by genetic alterations that promote tumor growth and progression. However, recent research has highlighted the importance of non-genetic factors in shaping cancer evolution and influencing therapeutic outcomes. Non-genetic heterogeneity refers to diverse subpopulations of cancer cells within breast tumors, exhibiting distinct phenotypic and functional properties. These subpopulations can arise through various mechanisms, including clonal evolution, genetic changes, epigenetic changes, and reversible phenotypic transitions. Although genetic and epigenetic changes are important points of the pathology of breast cancer yet, the immune system also plays a crucial role in its progression. In clinical management, histologic and molecular classification of BC are used. Immunological subtyping of BC has gained attention in recent years as compared …
Anahtar Kelimeler
Immune subtypes | Tumor immune microenvironment | Drug resistance | Non-genetic heterogeneity | Breast cancer